Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Troajan
I still think no bottom
This is the reality of this stocks market losing money
How this has gone
Another Finncap winner
Nothing was the answer. Delisted and I doubt it will ever be heard of again. Just a line in the stocks going into administration in a few months.
A red flag is that the CEO (now ex-) left, immediately without notice period, just 4 days before H1 end.
Any skeletons in the cupboard?
https://byotrolplc.com/wp-content/uploads/2023/09/27.09.23-Directorate-Change.pdf
Huge red flag is their severe cash shortage position and inability to raise cash.
The company's TU showed they have severe cash shortage and therefore are likely to run out soon.
"Our cash position remains tight, but is sufficient to finance current operations, assuming some noncore cost cutting, some reduction in investment, and expected and (in some cases accelerated)
receipts of cash from (already-contracted) IP transactions. "
https://byotrolplc.com/wp-content/uploads/2023/11/2023.11.13_Trading_Update.pdf
The assumption they mentioned in the TU didn't happen. So they are likely to run out of cash soon.
https://byotrolplc.com/wp-content/uploads/2023/12/2023.12.07_Interim_Results.pdf
Troajan
A little rise
Mannan....ime tellin ya.....your on the ending of that downtrend
lets see
No bottom
055?...could be very near the bottom...near az dammit#
let's see
52 Week High 2.60
52 Week High Date 24-May-2023
52 Week Low 0.65
52 Week Low Date 14-Nov-2023
Like many covid stocks that went to the moon, this has turned bad for those that held on. Not worth more than a million so expect this to fall to 0.25 to 0.30. Dire results today but then it was a superstock during covid
So how long would it be from patent to licence the IP....the same as Solvay and Actizone ? This might also influence PI short term investment decisions somewahat.
From patent to product is a long haul. This might influence PI short term investment decisions.
I asked Google AI Bard: are there any regulatory constraints in developing and selling these OTC products in the UK?
It replied "yes" and elaborated thus:
"Yes, there are regulatory constraints in developing and selling OTC products in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating medicines in the UK. The MHRA has a number of requirements that must be met before an OTC product can be developed and sold in the UK. These requirements include:
The product must be safe and effective. The MHRA will require evidence to demonstrate that the product is safe and effective for its intended use.
The product must be labelled correctly. The label must include information about the ingredients, dosage, and directions for use.
The product must be manufactured in a compliant facility. The manufacturing facility must meet the MHRA's standards for good manufacturing practice.
In addition to the MHRA, there are also other regulatory bodies that may need to be involved in the development and sale of OTC products in the UK. These bodies include:
The Food Standards Agency (FSA) is responsible for regulating food safety in the UK. The FSA may need to be involved if the OTC product contains food ingredients.
The Advertising Standards Authority (ASA) is responsible for regulating advertising in the UK. The ASA may need to be involved if the OTC product is advertised to consumers.
If you are considering developing and selling an OTC product in the UK, it is important to contact the MHRA and other relevant regulatory bodies early in the process. This will help to ensure that your product meets all of the necessary requirements and that it can be successfully developed and marketed.
Here are some additional resources that you may find helpful:
MHRA website: https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
FSA website: https://www.food.gov.uk/
ASA website: https://www.asa.org.uk/"
Bladey,
"but thinking they may need to raise some cash looking at final results IMO"
I also think they will need to raise some cash soon.
Despite the biggest pandemic in 100yrs from which they should've gained huge cash, they still had to have a fundraising last August. If they had to have one post the biggest pandemic then I'd thought they would need another soon.
They raised Β£1m last August.
https://byotrolplc.com/wp-content/uploads/2022/07/2022.07.28_CLN_financing_FINAL.pdf
Today's rns is a registration. The question is how much will they earn from it and crucially, when?
They were presented with the biggest opportunity when Covid hit.
Now WHO has declared the pandemic emergency is over.
Look around and hardly anybody bothers wearing masks nor using sanitisers.
WHO says Covid-19 is no longer a global health emergency
https://edition.cnn.com/2023/05/05/health/who-ends-covid-health-emergency/index.html
Before the close it was down to NT and at 2.1-2.3p somebody paid 2.5p for 399k so it was mm games the spike down because I was trying to get size and there was a brief quote at 2.18p but somebody took that and then bang the traders piled back in. Will be up first thing, guess you could wait for a shake and traders to sell first if you like the story
Great news ;)
"This new approval means we can now make specific long-lasting efficacy claims against viruses, which should in turn significantly increase the commercial potential of our U.S. formulations," Executive Director David Traynor said.
The infection prevention-and-control technology company also said that it continues to advance alliances and commercial opportunities in the U.S.
THIS COULD BE SOLD TO A MAJOR TO SUPPLY TO HOSPITALS
Nice news, but thinking they may need to raise some cash looking at final results IMO
Some chunky arrivals there
This is where the tumbleweed gif goes, right?
Anyone still holding apart from me?
Good effort FlagStaff.
Now see if you can find some new investors?